Hinokitiol reduces matrix metalloproteinase expression by inhibiting Wnt/β-Catenin signaling in vitro and in vivo

International Immunopharmacology

Volumn 23, Issue 1, 2014, Pages 85-91

  Li, Jin ^a   Zhou, Xin Die ^a   Yang, Kong He ^a   Fan, Teng Di ^a   Chen, Wei Ping ^a   Jiang, Li Feng ^a   Bao, Jia Peng ^a   Wu, Li Dong ^a   Xiong, Yan ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Hinokitiol; Matrix metalloproteinase; Osteoarthritis; catenin

Indexed keywords

BETA CATENIN; COLLAGENASE 3; INTERLEUKIN 1BETA; INTERSTITIAL COLLAGENASE; IODOACETIC ACID; MATRIX METALLOPROTEINASE; STROMELYSIN; THUJAPLICIN; WNT PROTEIN; ANTIINFLAMMATORY AGENT; BETA-THUJAPLICIN; COLLAGEN TYPE 2; TERPENE; TROPOLONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CARTILAGE DEGENERATION; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANALOGS AND DERIVATIVES; ANIMAL; ANIMAL MODEL; CELL CULTURE; CUPRESSACEAE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; INBRED RAT STRAIN; KNEE; METABOLISM; OSTEOARTHRITIS; PATHOLOGY; PHYSIOLOGY; PHYTOTHERAPY; SIGNAL TRANSDUCTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BETA CATENIN; CELLS, CULTURED; CHONDROCYTES; COLLAGEN TYPE II; CUPRESSACEAE; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-1BETA; KNEE; MATRIX METALLOPROTEINASES; MODELS, ANIMAL; MONOTERPENES; OSTEOARTHRITIS; PHYTOTHERAPY; RATS; RATS, INBRED STRAINS; SIGNAL TRANSDUCTION; TROPOLONE; WNT PROTEINS;

EID: 84906965339     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2014.08.012     Document Type: Article

References (31)

1. R.C. Lawrence, D.T. Felson, C.G. Helmick, L.M. Arnold, H. Choi, and R.A. Deyo Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II Arthritis Rheum 58 1 2008 26 35
2. R.F. Loeser, S.R. Goldring, C.R. Scanzello, and M.B. Goldring Osteoarthritis: a disease of the joint as an organ Arthritis Rheum 64 6 Jun. 2012 1697 1707
3. E. Seeman, J.L. Hopper, L.A. Bach, M.E. Cooper, E. Parkinson, and J. McKay Reduced bone mass in daughters of women with osteoporosis N Engl J Med 320 9 Mar. 2 1989 554 558
4. D.T. Felson Epidemiology of hip and knee osteoarthritis Epidemiol Rev 10 1988 1 28
5. T. Neogi, and Y. Zhang Osteoarthritis prevention Curr Opin Rheumatol 23 2011 185 191
6. B. Staal, B.O. Williams, F. Beier, G.F. Vande Woude, and Y.W. Zhang Cartilage-specific deletion of Mig-6 results in osteoarthritis-like disorder with excessive articular chondrocyte proliferation Proc Natl Acad Sci U S A 111 7 Feb. 18 2014 2590 2595
7. M.B. Goldring The role of the chondrocyte in osteoarthritis Arthritis Rheum 43 9 Sep. 2000 1916 1926
8. W.P. Chen, Y. Xiong, Y.X. Shi, P.F. Hu, J.P. Bao, and L.D. Wu Astaxanthin reduces matrix metalloproteinase expression in human chondrocytes Int Immunopharmacol 19 1 Mar. 2014 174 177
9. B. Pasternak, and P. Aspenberg Metalloproteinases and their inhibitors-diagnostic and therapeutic opportunities in orthopedics Acta Orthop 80 6 Dec. 2009 693 703
10. K.S. Santangelo, G.J. Nuovo, and A.L. Bertone In vivo reduction or blockade of interleukin-1beta in primary osteoarthritis influences expression of mediators implicated in pathogenesis Osteoarthritis Cartilage 20 2012 1610 1618
11. D.S. Bramono, J.C. Richmond, P.P. Weitzel, D.L. Kaplan, and G.H. Altman Matrix metalloproteinases and their clinical applications in orthopaedics Clin Orthop Relat Res 428 Nov. 2004 272 285
12. L.J. Crofford, P.E. Lipsky, P. Brooks, S.B. Abramson, L.S. Simon, and L.B. van de Putte Basic biology and clinical application of specific cyclooxygenase-2 inhibitors Arthritis Rheum 43 1 Jan. 2000 4 13
13. J. Zhao, K. Fujita, and K. Sakai Reactive oxygen species, nitric oxide, and their interactions play different roles in Cupressus lusitanica cell death and phytoalexin biosynthesis New Phytol 175 2 2007 215 229
14. K.H. Lin, J.R. Kuo, W.J. Lu, C.L. Chung, D.S. Chou, and S.Y. Huang Hinokitiol inhibits platelet activation ex vivo and thrombus formation in vivo Biochem Pharmacol 85 10 May 15 2013 1478 1485
15. Y. Arima, Y. Nakai, R. Hayakawa, and T. Nishino Antibacterial effect of beta-thujaplicin on staphylococci isolated from atopic dermatitis: relationship between changes in the number of viable bacterial cells and clinical improvement in an eczematous lesion of atopic dermatitis J Antimicrob Chemother 51 1 Jan. 2003 113 122
16. Y. Morita, E. Matsumura, T. Okabe, T. Fukui, T. Ohe, and N. Ishida Biological activity of beta-dolabrin, gamma-thujaplicin, and 4-acetyltropolone, hinokitiol-related compounds Biol Pharm Bull 27 10 Oct. 2004 1666 1669
17. M. Koufaki, E. Theodorou, X. Alexi, F. Nikoloudaki, and M.N. Alexis Synthesis of tropolone derivatives and evaluation of their in vitro neuroprotective activity Eur J Med Chem 45 3 Mar. 2010 1107 1112
18. S. Liu, and H. Yamauchi p27-Associated G1 arrest induced by hinokitiol in human malignant melanoma cells is mediated via down-regulation of pRb, Skp2 ubiquitin ligase, and impairment of Cdk2 function Cancer Lett 286 2 Dec. 28 2009 240 249
19. M.J. Alcaraz, J. Megías, I. García-Arnandis, V. Clérigues, and M.I. Guillén New molecular targets for the treatment of osteoarthritis Biochem Pharmacol 80 1 Jul. 1 2010 13 21
20. Q. Ding, H. Zhong, Y. Qi, Y. Cheng, W. Li, and S. Yan Anti-arthritic effects of crocin in interleukin-1β-treated articular chondrocytes and cartilage in a rabbit osteoarthritic model Inflamm Res 62 1 Jan. 2013 17 25
21. K.J. Livak, and T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2T method Methods 25 2001 402 408
22. D.R. Sagar, S. Ashraf, L. Xu, J.J. Burston, M.R. Menhinick, and C.L. Poulter Osteoprotegerin reduces the development of pain behaviour and joint pathology in a model of osteoarthritis Ann Rheum Dis 73 8 Aug. 2014 1158 1565 10.1136/annrheumdis-2013-203260
23. S.P. Ivanavicius, A.D. Ball, C.G. Heapy, F.R. Westwood, F. Murray, and S.J. Read Structural pathology in a rodent model of osteoarthritis is associated with neuropathic pain: increased expression of ATF-3 and pharmacological characterisation Pain 128 3 Apr. 2007 272 282
24. L.H. Weng, C.J. Wang, J.Y. Ko, Y.C. Sun, and F.S. Wang Control of Dkk-1 ameliorates chondrocyte apoptosis, cartilage destruction, and subchondral bone deterioration inosteoarthritic knees Arthritis Rheum 62 5 May 2010 1393 1402
25. H.J. Mankin, H. Dorfman, L. Lippiello, and A. Zarins Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. II. Correlation of morphology with biochemical and metabolic data J Bone Joint Surg Am 53 1971 523 537
26. M.B. Goldring, and F. Berenbaum The regulation of chondrocyte function by proinflammatory mediators: prostaglandins and nitric oxide Clin Orthop Relat Res Suppl. 427 Oct. 2004 S37 S46 [Review]
27. M.K. Kim, H.J. Park, Y.D. Kim, M.H. Ryu, T. Takata, and S.K. Bae Hinokitiol increases the angiogenic potential of dental pulp cells through ERK and p38MAPK activation and hypoxia-inducible factor-1α (HIF-1α) upregulation. Arch Oral Biol. 59 2), Feb. 2014 102 110 10.1016/j.archoralbio.2013.10.009
28. M. Chen, M. Zhu, H. Awad, T.F. Li, T.J. Sheu, and B.F. Boyce Inhibition of beta-catenin signalling causes defects in postnatal cartilage development J Cell Sci 121 2008 1455 1465
29. Y. Kawano, and R. Kypta Secreted antagonists of the Wnt signaling pathway J Cell Sci 116 2003 2627e34
30. B. Mao, W. Wu, G. Davidson, J. Marhold, M. Li, and B.M. Mechler Kremen proteins are Dickkopf receptors that regulate Wnt/beta-catenin signaling Nature 417 6889 Jun. 6 2002 664 667
31. Y. Tang, X. Zhou, B. Gao, X. Xu, J. Sun, and L. Cheng Modulation of Wnt/β-catenin signaling attenuates periapical bone lesions J Dent Res 93 2 Feb. 2014 175 182